Gene: STK39
Official Full Name: serine/threonine kinase 39provided by HGNC
Gene Summary: This gene encodes a serine/threonine kinase that is thought to function in the cellular stress response pathway. The kinase is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled cotransporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27620 | STK39 Knockout cell line (HeLa) | Human | STK39 | 1:3~1:6 | Negative | Online Inquiry |
KO27621 | STK39 Knockout cell line (HCT 116) | Human | STK39 | 1:2~1:4 | Negative | Online Inquiry |
KO27622 | STK39 Knockout cell line (HEK293) | Human | STK39 | 1:3~1:6 | Negative | Online Inquiry |
KO27623 | STK39 Knockout cell line (A549) | Human | STK39 | 1:3~1:4 | Negative | Online Inquiry |
STK39 Gene Knockout Cell Lines represent a revolutionary approach to studying the biological functions of the STK39 gene, a serine/threonine kinase involved in various cellular processes, including cell growth, differentiation, and apoptosis. These cell lines are genetically engineered to possess a complete knockout of the STK39 gene, allowing researchers to evaluate the consequences of its absence on cellular behavior and physiology.
The primary function of these knockout cell lines lies in their ability to elucidate the role of STK39 in signal transduction pathways and its implications in diseases such as cancer and metabolic disorders. By analyzing the growth patterns, survival rates, and metabolic activities of the STK39 knockout cells compared to wild-type cells, researchers can gain insights into the gene's physiological significance and potential as a therapeutic target.
From a scientific standpoint, STK39 Gene Knockout Cell Lines are invaluable in both basic research and clinical settings. They serve as a platform for detailed exploration of gene function and interaction within various biological systems. Additionally, they are integral in drug discovery and development, offering a model for testing the efficacy of novel compounds aimed at manipulating STK39-related pathways.
The unique selling points of these knockout cell lines lie in their high specificity and robust genetic modification, ensuring reliable and reproducible results that are often not achievable with other available models. Compared to traditional knockdown approaches, gene knockout offers a more definitive elimination of gene function, which is essential for clarity in experimental outcomes.
Researchers and clinicians will find STK39 Gene Knockout Cell Lines to be an essential resource for advancing their investigations and clinical applications regarding the STK39 gene. By providing a precise tool for genetic studies, these cell lines facilitate groundbreaking discoveries and therapeutic advancements.
Our company prides itself on delivering high-quality biological products and cell lines, backed by extensive scientific research and expertise in genetic engineering. We are committed to supporting the scientific community with innovative solutions that enhance research capabilities and drive progress in the understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.